Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Quarterly results
Consulting agrmnt
CC transcript
Employment agrmnt
Director departure
Appointed COO
Appointed director
Asset disposition

Aeon Global Health Corp. (AGHC) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/05/2019 8-K Other Events
10/01/2019 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "DEBT CONVERSION AGREEMENT This Debt Conversion Agreement is entered into effective as of ________, 2019 by and between __________ and Aeon Global Health Corp., a Delaware corporation , with reference to the following facts: WHEREAS, Debt Holder holds promissory notes and other debt totaling $_________, of which the Company and the Debt Holder desire to convert $_________ into common shares of the Company. NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Debt Holder and the Company agree as follows: 1. Conversion to Common Stock. Effective as of _________, 2019, $_________ of the Debt shall be converted into common shares at a price per share of $0.105 for an aggregate number of shares of __________. Upon execution of this Agr..."
01/24/2019 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
01/23/2019 8-K Submission of Matters to a Vote of Security Holders
12/21/2018 8-K Other Events
12/11/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/01/2018 8-K Quarterly results
09/13/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/24/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Grid Note",
"Form of Settlement and Restructuring Agreement",
"Form of Note Exchange Agreement",
"Form of Consent and Amendment Agreement",
"Form of Amendment to Amended and Restated Security Agreement"
07/02/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/20/2018 8-K Other Events
04/03/2018 8-K Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce...
03/28/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of New Senior Note",
"Form of Note Exchange Agreement",
"Form of Consent and Amendment Agreement",
"Form of Amendment to amended and Restated Security Agreement"
02/01/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
Docs: "Certificate of Amendment to Certificate of Incorporation",
"Authentidate Announces Name Change to AEON Global Health Corp to Reflect Broader Healthcare Focus and Innovative Solutions"
01/10/2018 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Aeon Global Health Names Armando Moncada, MD, FCAP as Chief Medical Officer of its Anatomic Pathology Business Company Also Announces Agreement to Acquire Certain IP Assets of PCG Molecular, LLC For Immediate Release: Gainesville, GA, January 10, 2018: Aeon Global Health , a growth-oriented provider of personalized, clinically actionable medical informatics and telemedicine, announced today that Armando Moncada, MD, FCAP, has been appointed to the position of Chief Medical Officer of its Anatomic Pathology business line. Dr. Moncada has more than 20 years’ experience in the pathology field, the last ten of which he served as Chief Medical Officer of PCG Molecular. He has expertise in the fields of gynecologic, breast, and head and neck pathology and cytopathology as well as in molecular pa..."
12/12/2017 8-K Submission of Matters to a Vote of Security Holders
12/01/2017 8-K/A Financial Statements and Exhibits
Docs: "Letter of Resignation of Richard Hersperger"
10/02/2017 8-K Quarterly results
09/14/2017 8-K Quarterly results
09/13/2017 8-K Quarterly results
06/07/2017 8-K Form 8-K - Current report
04/24/2017 8-K Form 8-K - Current report
03/24/2017 8-K Form 8-K - Current report
03/03/2017 8-K Form 8-K - Current report
02/22/2017 8-K Form 8-K - Current report
02/06/2017 8-K Form 8-K - Current report
01/20/2017 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Response Letter of Ronald Oklewicz"
01/18/2017 8-K Form 8-K - Current report
12/21/2016 8-K Form 8-K - Current report
12/13/2016 8-K Form 8-K - Current report
11/17/2016 8-K/A Financial Statements and Exhibits
Docs: "Consent of EisnerAmper, LLP, Independent Registered Public Accounting Firm of Peachstate Health Management LLC, d/b/a AEON Clinical Laboratories",
"Unaudited pro forma condensed combined financial statements"
08/12/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/13/2016 8-K Form 8-K - Current report
06/06/2016 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy